PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
Quick Stats
Feb 02, 202646.9
AI Score
HOLD0.35
Volume Ratio
Mar 16, 2026
Next Earnings
17
+ve Days (30d)
12
-ve Days (30d)
PMCB Stock Summary
Last updated Feb 02, 2026
PMCB is currently trading at $0.819, positioned below its 200-day moving average of $0.99, suggesting bearish momentum. The stock has a 52-week range of $0.63 to $1.9.
Technical Analysis: The 50-day moving average stands at $0.87, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.629, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.059, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PMCB at 46.9/100 with a HOLD recommendation.
PMCB (PharmaCyte Biotech, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.629 |
| CMF (20) | 0.059 |
| ROC (10) | -7.988 |
| ADX (14) | 21.217 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.003 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -79.931 |
| MFI (14) | 72.29 |
PMCB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PMCB Price vs Max Options Open Interest
PMCB Max Change In Options Open Interest
PMCB Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PMCB Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PMCB Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PMCB Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PharmaCyte Biotech, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PMCB Moving Averages Analysis
PMCB (PharmaCyte Biotech, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 0.89 |
| 20 | 0.88 |
| 30 | 0.84 |
| 50 | 0.87 |
| 100 | 0.92 |
| 200 | 0.99 |
PMCB Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 8.3 million |
| Earnings/Share ($) | -1.06 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |